29 April 2026
: Case report
Hemolytic Glaucoma Following Intravitreal Aflibercept Injection for Age-Related Macular Degeneration: A Case Report
Diagnostic / therapeutic accidents
Hiroki SanoDOI: 10.12659/AJCR.952247
Am J Case Rep 2026; 27:e952247
Figure 2 Anterior segment findings 3 days after the tenth intravitreal aflibercept injection(A) Anterior segment photograph shows subconjunctival hemorrhage and diffuse anterior chamber haze due to suspended erythrocytes. The yellow arrow indicates the intravitreal injection site. Subconjunctival hemorrhage may extend beyond the injection site, explaining its inferior distribution in this image. (B) Slit-lamp photograph shows mild corneal edema, a distinct approximately 1-mm blood-fluid level in the inferior anterior chamber (white arrow), and fine backscatter within the slit beam consistent with suspended erythrocytes.






